These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33990520)

  • 1. Low Risk of Central Line-associated Bloodstream Infections in Pediatric Hematology/Oncology Patients.
    Kristinsdottir I; Haraldsson A; Gudlaugsson O; Thors V
    Pediatr Infect Dis J; 2021 Sep; 40(9):827-831. PubMed ID: 33990520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of mucosal barrier injury laboratory-confirmed bloodstream infection (MBI-LCBI) on central line-associated bloodstream infections (CLABSIs) in department of hematology at single university hospital in Japan.
    Kato Y; Hagihara M; Kurumiya A; Takahashi T; Sakata M; Shibata Y; Kato H; Shiota A; Watanabe H; Asai N; Koizumi Y; Yamagishi Y; Mikamo H
    J Infect Chemother; 2018 Jan; 24(1):31-35. PubMed ID: 29066217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central Line-Associated Bloodstream Infections in Children With Hematologic and Oncologic Diseases: First Prevalence Results From a University Hospital.
    Özalp Gerçeker G; Yardımcı F; Aydınok Y
    J Pediatr Oncol Nurs; 2019; 36(5):327-336. PubMed ID: 31027430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central venous catheter-associated bloodstream infections in pediatric hematology-oncology patients and effectiveness of antimicrobial lock therapy.
    Tsai HC; Huang LM; Chang LY; Lee PI; Chen JM; Shao PL; Hsueh PR; Sheng WH; Chang YC; Lu CY
    J Microbiol Immunol Infect; 2015 Dec; 48(6):639-46. PubMed ID: 25311403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of central line bundles on the timing of catheter-associated bloodstream infections and their microbiological distribution in critically ill children.
    Devrim İ; Sandal OS; Çelebi MY; Hepduman P; Gönüllü A; Atakul G; Kara AA; Oruç Y; Gülfidan G; Bayram N; Ağın H
    Eur J Pediatr; 2023 Oct; 182(10):4625-4632. PubMed ID: 37555974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Characteristics and Risk Factors of Long-term Central Venous Catheter-associated Bloodstream Infections in Children.
    Moon HM; Kim S; Yun KW; Kim HY; Jung SE; Choi EH; Lee HJ
    Pediatr Infect Dis J; 2018 May; 37(5):401-406. PubMed ID: 29194165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central Line Associated Blood Stream Infections in Pediatric Hematology/Oncology Patients With Different Types of Central Lines.
    Hord JD; Lawlor J; Werner E; Billett AL; Bundy DG; Winkle C; Gaur AH;
    Pediatr Blood Cancer; 2016 Sep; 63(9):1603-7. PubMed ID: 27198806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Pediatric Central Venous Access Device Placement With Concomitant Surgical Procedures.
    Bludevich BM; Chandler NM; Gonzalez R; Danielson PD; Snyder CW
    J Surg Res; 2021 Mar; 259():451-457. PubMed ID: 33616076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for central line-associated bloodstream infection in pediatric oncology patients with a totally implantable venous access port: A cohort study.
    Viana Taveira MR; Lima LS; de Araújo CC; de Mello MJ
    Pediatr Blood Cancer; 2017 Feb; 64(2):336-342. PubMed ID: 27666952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of a Best Practice Prevention Bundle on Central Line-associated Bloodstream Infection (CLABSI) Rates and Outcomes in Pediatric Hematology, Oncology, and Hematopoietic Cell Transplantation Patients in Inpatient and Ambulatory Settings.
    Ardura MI; Bibart MJ; Mayer LC; Guinipero T; Stanek J; Olshefski RS; Auletta JJ
    J Pediatr Hematol Oncol; 2021 Jan; 43(1):e64-e72. PubMed ID: 32960848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central line-associated bloodstream infection in childhood malignancy: Single-center experience.
    Miliaraki M; Katzilakis N; Chranioti I; Stratigaki M; Koutsaki M; Psarrou M; Athanasopoulos E; Stiakaki E
    Pediatr Int; 2017 Jul; 59(7):769-775. PubMed ID: 28376269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central Line-Associated Bloodstream Infection Risk Factors in a Pediatric Population.
    Trembath HE; Caruso DM; McLean SE; Akinkuotu AC; Hayes Dixon AA; Phillips MR
    Am Surg; 2024 Jan; 90(1):69-74. PubMed ID: 37571962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central line-associated bloodstream infection in neonatal intensive care units.
    Blanchard AC; Fortin E; Rocher I; Moore DL; Frenette C; Tremblay C; Quach C
    Infect Control Hosp Epidemiol; 2013 Nov; 34(11):1167-73. PubMed ID: 24113600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage strategy for long-term central venous catheter-associated Staphylococcus aureus infections in children: a multi-centre retrospective study in France.
    Devautour C; Poey N; Lagier J; Launay E; Cerdac A; Vergnaud N; Berneau P; Parize P; Ferroni A; Tzaroukian L; Pinhas Y; Pinquier D; Lorrot M; Dubos F; Caseris M; Ouziel A; Chalumeau M; Cohen JF; Toubiana J
    J Hosp Infect; 2024 Aug; 150():125-133. PubMed ID: 38880286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ambulatory pediatric oncology CLABSIs: epidemiology and risk factors.
    Rinke ML; Milstone AM; Chen AR; Mirski K; Bundy DG; Colantuoni E; Pehar M; Herpst C; Miller MR
    Pediatr Blood Cancer; 2013 Nov; 60(11):1882-9. PubMed ID: 23881643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Central Line-Associated Bloodstream Infection Rates Among Children With Immune Compromised Conditions: An 11-Year Review.
    Linder LA; Gerdy C; Jo Y; Wilson A
    J Pediatr Oncol Nurs; 2018; 35(6):382-391. PubMed ID: 29665727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taurolidine-citrate lock solution for the prevention of central line-associated bloodstream infection in paediatric haematology-oncology and gastrointestinal failure patients with high baseline central-line associated bloodstream infection rates.
    Chong CY; Ong RY; Seah VX; Tan NW; Chan MY; Soh SY; Ong C; Lim AS; Thoon KC
    J Paediatr Child Health; 2020 Jan; 56(1):123-129. PubMed ID: 31145505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central-line-associated bloodstream infections and central-line-associated non-CLABSI complications among pediatric oncology patients.
    Kelada AS; Foster TB; Gagliano GC; Worley S; Tang A; Arakoni VA; Foster CB
    Infect Control Hosp Epidemiol; 2023 Mar; 44(3):377-383. PubMed ID: 35475427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central line-associated bloodstream infections in cancer patients: An experience from a tertiary care cancer centre.
    Agrawal SK; Gautam H; Choudhary AH; Das BK; Kumar L; Kapil A
    Indian J Med Microbiol; 2019; 37(3):376-380. PubMed ID: 32003336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes in Pediatric Central Line-associated Bloodstream Infections Treated With Antimicrobial Locks: A 14-Year Retrospective Analysis.
    Walker LW; Visweswaran S; Nowalk AJ
    Pediatr Infect Dis J; 2023 Jun; 42(6):473-478. PubMed ID: 36854127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.